Skip to main content
. 2022 Sep 19;12(9):1534. doi: 10.3390/jpm12091534

Table 2.

Treatment approach.

Treatment Modality Total
n = 106
Patients Aged 50–69 Years
N = 49 (46.2%)
Patients Aged ≥ 70 Years
N = 57 (53.8%)
p-Value
Neoadjuvant radiotherapy or chemotherapy 17 (16.1) 9 (8.5) 8 (7.5) 0.546
Operative setting Elective surgery 85 (80.2) 40 (37.7) 45 (42.4) 0.729
Urgent surgery 21 (19.8) 9 (8.5) 12 (11.3)
Surgical procedure Segmental resection 81 (76.4) 37 (34.9) 44 (41.5) 0.836
Anterior resection 13 (12.3) 6 (5.6) 7 (6.6)
Hartmann’s procedure 6 (5.7) 2 (1.9) 4 (3.8)
Abdominoperineal resection 2 (1.9) 1 (0.9) 1 (0.9)
Surgical approach Open surgery 74 (69.8) 33 (31.1) 41 (38.6) 0.608
Laparoscopic 32 (30.2) 16 (15) 16 (15)
Associated resection None 67 (63.2) 30 (28.3) 37 (34.9) 0.679
1 organ 23 (21.7) 10 (9.4) 13 (12.2)
≥2 organs 16 (15.1) 9 (8.4) 7 (6.6)
Synchronous liver resection 11 (10.4) 8 (7.5) 3 (2.8) 0.063
Stoma 22 (21.7) 10 (9.4) 12 (11.3) 0.969
Lymph node involvement 59 (55.7) 25 (23.5) 34 (32) 0.372
Surgical margins status R0 98 (92.5) 46 (43.3) 52 (49) 0.723
R1 8 (7.5) 3 (2.8) 5 (4.7)
Adjuvant chemotherapy 63 (59.4) 36 (33.9) 27 (25.4) 0.006
Delay from surgery to chemotherapy, days Mean 37 34 40 <0.001